NCT06808646View on ClinicalTrials.gov

A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 17, 2025

Primary Completion Date

February 25, 2025

Study Completion Date

February 25, 2025

Conditions
Drug-drug Interaction Study
Interventions
DRUG

pitavastatin

Single oral administration

DRUG

pitavastatin single dose combined with ceftobiprole

Single oral pitavastatin co-administered with IV ceftobiprole

Trial Locations (1)

9728

ICON Early Clinical & Bioanalytical Solutions, Groningen

Sponsors
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Basilea Pharmaceutica

INDUSTRY